Cardiac Dysfunction Associated with Lacosamide in a Premature Infant with Hypoxic Ischemic Encephalopathy: A Case Report
Lacosamide (Vimpat Harris FRC Corporation, 2022 UCB, Inc. Smyrna, GA 30080) is an antiseizure medication, which acts through blockage of voltage-gated neuronal sodium channels. Its recent implementation in the neonatal population has been extrapolated from adult and pediatric data suggesting a favor...
Saved in:
| Main Authors: | Trassanee Chatmethakul, Amy H. Stanford, Danielle R. Rios, Adrianne R. Bischoff, Theresa Czech, Patrick J. McNamara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical Publishers, Inc.
2024-07-01
|
| Series: | American Journal of Perinatology Reports |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2447-8662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of lacosamide on cortical spreading depolarization in mice
by: Chisato Iba, et al.
Published: (2025-07-01) -
Saliva-based lacosamide monitoring paves the way toward personalized epilepsy pharmacotherapy
by: Yoonhyuk Jang, et al.
Published: (2025-05-01) -
CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY
by: E. A. Pyadushkina, et al.
Published: (2016-12-01) -
Use of lacosamide in children: experience of a tertiary medical care center in Brazil
by: Tayla Taynan Romão, et al.
Published: (2022-11-01) -
EFFICACY OF VIMPAT (LACOSAMIDE) TN THE TREATMENT OF DRUG-RESISTANT CRYPTOGENIC FOCAL EPILEPSY WITH FOCAL AUTOMOTOR AND SECONDARILY GENERALIZED SEIZURES (A CLINICAL CASE)
by: M. B. Mironov, et al.
Published: (2015-07-01)